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L-3,3 ,5-triiodothyronine (T3) administration upregulates nuclear factor-E2-related factor 2 (Nrf2) in rat liver, which is redox-
sensitive transcription factor mediating cytoprotection. In this work, we studied the role of Kupﬀer cell respiratory burst activity,
a process related to reactive oxygen species generation and liver homeostasis, in Nrf2 activation using the macrophage inactivator
gadolinium chloride (GdCl3; 10mg/kg i.v. 72h before T3 [0.1mg/kg i.p.]) or NADPH oxidase inhibitor apocynin (1.5mmol/L
added to the drinking water for 7 days before T3), and determinations were performed 2 h after T3.T 3 increased nuclear/cytosolic
Nrf2 content ratio and levels of heme oxygenase 1 (HO-1), catalytic subunit of glutamate cysteine ligase, and thioredoxin (Western
blot)overcontrolvalues,proteinswhosegenetranscriptionisinducedbyNrf2.ThesechangesweresuppressedbyGdCl3 treatment
prior to T3, an agent-eliciting Kupﬀer-cell depletion, inhibition of colloidal carbon phagocytosis, and the associated respiratory
burst activity, with enhancement in nuclear inhibitor of Nrf2 kelch-like ECH-associated protein 1 (Keap1)/Nrf2 content ratios
suggesting Nrf2 degradation. Under these conditions, T3-induced tumor necrosis factor-α (TNF-α) response was eliminated by
previous GdCl3 administration. Similar to GdCl3, apocynin given before T3 signiﬁcantly reduced liver Nrf2 activation and HO-
1 expression, a NADPH oxidase inhibitor eliciting abolishment of colloidal carbon-induced respiratory burst activity without
altering carbon phagocytosis. It is concluded that Kupﬀer cell functioning is essential for upregulation of liver Nrf2-signaling
pathway by T3. This contention is supported by suppression of the respiratory burst activity of Kupﬀer cells and the associated
reactive oxygen species production by GdCl3 or apocynin given prior to T3, thus hindering Nrf2 activation.
1.Introduction
Kupﬀer cells reside in liver sinusoids representing approx-
imately 35% of hepatic nonparenchymal cells. These liver
macrophages have scavenger receptors that are essential for
eliminating blood borne bacteria [1]. In addition, activated
Kupﬀer cells produce and release several mediators including
cytokines, lipid substances, and reactive oxygen species
(ROS), which can function locally or systemically to mediate
immune responses [1]. These responses play a key role
in the homeostatic adaptation to liver injury; however, if
dysregulated, they can induce acute or chronic liver damage
[2–4]. Cytotoxicity of Kupﬀer cells has been implicated in
ischemia-reperfusion (IR) injury, an inﬂammatory model
underlying drastic ROS generation [5], whereas precondi-
tioning strategies against IR injury have been associated with
moderate increases in ROS production [6, 7].
Thyroid hormone- (L-3,3 ,5-triiodothyronine, T3) in-
duced calorigenic eﬀects involving ROS generation in the
liver has been proposed as a preconditioning mechanism for
IR injury [8]. T3-induced ROS generation occurs at diﬀerent
subcellular sites of hepatocytes and in the respiratory burst
of Kupﬀer cells, triggering the activation of the transcription
factors nuclear factor-κB( N F - κB), signal transducer and
activator of transcription 3 (STAT3), and activating protein
1 (AP-1). Under these conditions, the redox upregulation2 The Scientiﬁc World Journal
of Kupﬀer cell-dependent expression of cytokines (tumor
necrosis factor-α (TNF-α), interleukin (IL)-1, and IL-6)
is achieved, which upon interaction with speciﬁc recep-
tors in hepatocytes trigger the expression of antioxidant
enzymes (manganese superoxide dismutase, inducible nitric
oxide synthase) [9, 10], antiapoptotic proteins (Bcl-2) [9],
and acute-phase proteins (haptoglobin, β-ﬁbrinogen) [11].
Theseresponses,andthepromotionofhepatocyteandKupf-
fer cell proliferation observed [12, 13], represent cytoprotec-
tive eﬀects reestablishing redox homeostasis, promoting cell
survival, and protecting the liver against IR injury [7].
Activation of nuclear factor-E2-related factor 2 (Nrf2)
also aﬀords cytoprotection, in addition to NF-κB-, STAT3-,
and AP-1-dependent signaling pathways, a transcription fac-
tor whose cytosol-to-nuclear translocation has been recently
found to be triggered by T3 administration through a
redox-dependent mechanism [14]. Nrf2 signaling is char-
acterized by its sensitivity to low levels to ROS [15],
controls the expression of antioxidant components, detoxiﬁ-
cation enzymes, membrane transporters, or 26S proteasome
components, and interplays with NF-κBa ﬀording anti-
inﬂammatory responses [16–19]. Thus, the cytoprotective
eﬀects of T3-induced liver Nrf2 activation may represent an
alternate mechanism for liver preconditioning, a condition
associatedwithKupﬀercellfunctioningthatmayconstitutea
new therapeutic option for liver surgery and liver transplan-
tation in man using reduced-size grafts from living donors
[7, 8, 20]. According to these considerations, the purpose
of this study was to investigate whether T3-induced liver
Nrf2 activation depends on the respiratory burst activity of
Kupﬀer cells, a process related to ROS generation and liver
homeostasis. For this purpose, Nrf2 activation, as assessed
by cytosol-to-nuclear translocation, was determined in rat
liver either without or with pretreatment with the Kupﬀer
cell inactivator gadolinium chloride (GdCl3)[ 21] or with the
NADPH oxidase inhibitor apocynin [22]p r i o rt oT 3. These
studies were correlated with the assessment of Kupﬀer cell
functioning by means of colloidal carbon phagocytosis and
the respective respiratory burst activity in perfused livers.
The expression of the antioxidant proteins heme oxygenase-
1 (HO-1), catalytic subunit of glutamate cysteine ligase
(GCLC), and thioredoxin (Trx) were chosen as prototypical
genes controlled by Nrf2 signaling, in addition to the levels
of the Nrf2 inhibitor kelch-like ECH-associated protein 1
(Keap1) [17–19].
2. Methods
2.1. Animal Treatments. Male Sprague-Dawley rats (Animal
Facility of the Institute of Biomedical Sciences, Faculty of
Medicine, University of Chile) weighing 180–200g, housed
on a 12-h light/dark cycle, and fed with rat chow and
water ad libitum, received a single intraperitoneal dose of
0.1mg of T3/kg body weight or equivalent volumes of the
hormone vehicle 0.1N NaOH (controls). Kupﬀer cells were
selectively eliminated by a single intravenous injection of
10mg of GdCl3/kg body weight [21]g i v e n7 2 hb e f o r e
T3 administration, and control animals received equivalent
volumes of saline. A separate group of rats was given the
selective NADPH oxidase inhibitor apocynin (1.5mmol/L)
added to the drinking water for 7 days prior to T3,
a protocol shown to eﬀectively inhibit NADPH oxidase
activity in rats [22] .S t u d i e sw e r ec a r r i e do u t2 ha f t e r
T3 administration in animals anesthetized with intraperi-
toneal (1mL/kg) zolazepam chlorhydrate (25mg/mL) and
tiletamine chlorhydrate (25mg/mL) (Zoletil-50; Virbac S/A,
Carros, France). In the group of rats subjected to GdCl3-T3-
combined treatment, levels of serum TNF-α were measured
by ELISA (UltraSensitive Cytoscreen kit, Biosource Inter-
national, Camarillo, CA, USA) according to manufacturer’s
speciﬁcations. Experimental animal protocols and animal
procedures complied with the Guide for the Care and Use
of Laboratory Animals (National Academy of Sciences, NIH
Publication 86-23, revised 1985) and were approved by
Ethics Committee of the Faculty of Medicine, University of
Chile (CBA 0269 FMUCH).
2.2. Kupﬀer-Cell Inactivation. Liver slices were obtained in
anesthetized (Zoletil-50) rats at 24 to 72h after-GdCl3,a n d
kinetic changes of ED2-immunolabelled Kupﬀer cells were
determined by immunohistochemistry using a commercial
kit (AbD Serotec, Oxford, UK). Brieﬂy, liver samples were
ﬁxedinphosphate-buﬀeredformalin(pH7.4)andincubated
with a primary mouse antibody to ED2, followed by incu-
bation with biotin-conjugated secondary goat antibody. Pos-
itive reactions were visualized with 3,3’-diaminobenzidine,
andresultsareexpressedasthenumberofcellsdeterminedin
10 diﬀerent 0.7mm2 areas per liver from 3 rats per timepoint
[23].
2.3. Liver Perfusion, Colloidal Carbon Uptake, and Carbon-
Induced Respiratory Activity. Livers from animals anes-
thetized with Zoletil-50 were perfused with a solution
containing 118mM NaCl, 4.8mM KCl, 1.2mM KH2PO4,
1.2mM MgSO4,2 . 5 m MC a C l 2,2 5 m MN a H C O 3,a n d
10mM glucose, equilibrated with and O2/CO2 mixture
(19:1, vol/vol) to give pH 7.4, through a cannula placed
in the portal vein. Perfusion was carried out at constant
ﬂow rates (3.5 to 4mL/g liver/min) and temperature (36 to
37◦C), without recirculation of the perfusate [13, 24]. After
15min equilibration of perfused livers, O2 consumption
(QO2) was determined in the eﬄuent perfusate collected
via a cannula placed in the vena cava and allowed to ﬂow
through a Clark-type oxygen electrode. For determination
of colloidal carbon uptake by perfused livers, suspensions
of India ink (Rotring, Hamburg, Germany) were prepared,
dialysed, and infused between 30 to 45min of perfusion
at the concentration of 0.5mg/mL. Perfusate samples were
taken every 10min in the presence and absence of the liver
to measure the absorbance of colloidal carbon at 623nm
[24] (speciﬁc extinction coeﬃcient of 0.97[mg/mL]−1)[ 13].
Rates of carbon uptake were calculated from inﬂuent minus
eﬄuent concentration diﬀerences, referred to the perfusion
ﬂow. The respiratory burst activity induced by colloidal
carbon infusion was assessed by the integration of the area
under the QO2 curves between 30 and 45min, and expressed
as μmol O2/g liver [13]. These parameters were determined
in control rats and in animals after 2h of T3 administrationThe Scientiﬁc World Journal 3
and pretreatment for 72h with GdCl3 or for 7 days with
apocynin prior to T3.
2.4. Western Blot Analysis of Nrf2, Keap1, HO-1, GCLC, and
Trx. Liver samples (100–500mg) frozen in liquid nitrogen
werehomogenizedandsuspendedinabuﬀersolutionpH7.9
containing10mMHEPES,1mMEDTA,0.6%NonidetP-40,
150mMNaCl,andproteaseinhibitors(1mMphenylmethyl-
sulfonyl ﬂuoride, 1μg/mL aprotinin, 1μg/mL leupeptin, and
1mM orthovanadate). Nuclear protein extracts (100μg) and
soluble protein fractions (60μg) were mixed with sample
loading buﬀer pH 6.8 (2% SDS, 0.0625M Tris, 10% glycerol,
and 2.5%β-mercaptoethanol) and heated at 95◦C for 5min,
separated on 12% polyacrylamide gels using SDS-PAGE
[25], and transferred to nitrocellulose membranes [26],
which were blocked for 1 hour at room temperature with
TBS-containing 5% bovine serum albumin. The blots were
washed with TBS containing 0.1% Tween 20 and hybridized
with either rabbit polyclonal antibodies for Nrf2, Keap1,
HO-1, GCLC, and Trx (Abcam, Cambridge, MA), or mouse
monoclonal antibodies for β-actin (ICN Biomedicals, Inc.,
Aurora,OH)and lamin A/C (BDTransductionLaboratories,
San Jos´ e, CA, USA). In all determinations, anti-β-actin was
used as internal control for cytosolic fractions, whereas
antilamin A/C was employed as internal control for nuclear
fractions.Inaddition,themembraneswerestainedwithanti-
α-tubulinoranti-laminA/Ctoconﬁrmcontaminationofthe
cytosolic and nuclear fractions. After extensive washing, the
antigen-antibody complexes weredetected using horseradish
peroxidase goat anti-rabbit IgG or goat anti-mouse IgG and
a SuperSignal West Pico Chemiluminescence kit detection
system (Pierce, Rockford, IL, USA). Bands were quantiﬁed
by densitometry using Scion Image (Scion Corp., Frederick,
MD).
2.5.Statistics. DatashowingGaussiandistributionaccording
to the Kolmogorov-Smirnov test are expressed as means ±
SEM for the number of separate experiments indicated.
One-way or two-way ANOVA and the Newman-Keuls, test
or Student’s t-test for unpaired data assessed the statistical
signiﬁcance (P<0.05) of diﬀerences between mean values as
indicated. All statistical analyses were computed employing
GraphPadPrismTM version2.0(GraphPadSoftwareInc.,San
Diego, CA, USA).
3. Results
Administration of the Kupﬀer cell inactivator GdCl3 to
euthyroid rats elicited a decrease in the number of ED2(+)
cells, with 95% (P<0.05) depletion observed at 72h
(Figure 1(a)), as assessed by immunohistochemical tech-
nique with ED2 antibody. Studies using the isolated perfused
liver revealed that, at 72h after treatment, GdCl3 reduced
by 86% and 83% (P<0.05) the rate of colloidal carbon
uptake (Figure 1(b)) and the associated carbon-induced
respiratory activity (Figure 1(c)), respectively, compared to
liver perfusions in the absence of carbon infusion. According
to these results, the inﬂuence of Kupﬀer cells on T3-induced
liver Nrf2 activation was studied by giving T3 at the time
of maximal ED2(+) Kupﬀer-cell inactivation (72h after
GdCl3), and studies on T3 action were carried out 2h after
T3 administration, time at which Nrf2 activation is attained
[14].
Liver Nrf2 activation induced at 2h after T3 admin-
istration was evidenced by the signiﬁcant 24% decrease
in the content of cytosolic Nrf2 (Figure 2(a)) and 434%
enhancement in that of nuclear Nrf2 (Figure 2(b)), with a
463% increase in nuclear/cytosolic Nrf2 ratio (Figure 2(c)).
Treatment with GdCl3 did not signiﬁcantmodiﬁy the liver
nuclear/cytosolic Nrf2 ratio when given alone (Figure 2(c)).
However, cytosolic and nuclear Nrf2 levels after combined
GdCl3-T3 protocol were comparable to control values (Fig-
ures 2(a) and 2(b)), leading to a net 91% decrease (P<
0.05) in the nuclear/cytosolic Nrf2 ratio compared to the
net eﬀect of T3 alone (Figure 2(c), inset). Under these
conditions, upregulation of liver HO-1 (Figure 2(d)), GCLC
(Figure 2(e)), and Trx (Figure 2(f))b yT 3 was suppressed
by the combined GdCl3-T3 treatment, without signiﬁcant
eﬀects of GdCl3 when given alone (Figures 2(d), 2(e) and
2(f)). These ﬁndings were observed concomitantly with 7.5-
fold increase in the serum TNF-α levels by T3, with a net
92% diminution being elicited by the combined GdCl3-T3
treatment (a) control, 2 ± 1( n = 9) pg TNF-α/mL; (b)
T3,1 5 ± 1( n = 3); (c) GdCl3,3 ± 2( n = 3);(d)
GdCl3-T3,4 ± 2( n = 3); (b) versus (a), (c), and (d),
P<0.05). Furthermore, liver Nrf2 inhibitor Keap1 levels in
the cytosol exhibited 75% reduction in T3-treated rats over
controls (Figure 3(a)), whereas those of nuclear Keap1 were
enhancedby173%(Figure 3(b)),withoutsigniﬁcantchanges
in nuclear Keap1/Nrf2 ratios (Figure 3(c)). Net diﬀerences in
the latter parameter indicate a substantial enhancement (P<
0.05) in animals subjected to combined GdCl3-T3 treatment
[(GdCl3 +T 3) − GdCl3]c o m p a r e dt or a t sg i v e nT 3 alone
[T3− control] (Figure 3(c), inset).
Administration of apocynin to euthyroid rats resulted
in 90% decrease (P<0.05) in carbon-induced respi-
ratory burst activity assessed in liver perfusion studies
(Figure 4(a)), without signiﬁcant changes in the rate of
colloidal carbon uptake (Figure 4(b)). Liver Nrf2 activation
byT3 administrationinvolvedsigniﬁcant48%decreaseinthe
content of cytosolic Nrf2 (Figure 5(a)), 675% enhancement
in nuclear Nrf2 levels (Figure 5(b)), and 14.9-fold increase
in nuclear/cytosolic Nrf2 ratio (Figure 5(c))o v e rc o n t r o l
values. Apocynin administration prior to T3 elicited 29%
diminution (P<0.05) in cytosolic Nrf2 (Figure 5(a)),
with comparable values of nuclear Nrf2 (Figure 5(b))a n d
nuclear/cytosolic Nrf2 ratios (Figure 5(c)) to those in rats
given apocynin alone, thus eliciting a net 65% reduction
in nuclear/cytosolic Nrf2 ratios (Figure 5(c), inset). Under
these conditions, T3-induced upregulation of liver HO-
1 levels was suppressed in apocynin-T3-treated animals
(Figure 5(d)).
4. Discussion
Kupﬀer cell functioning assessed in the isolated perfused rat
liver by means of colloidal carbon infusion allows the con-
tinuous estimation of the associated rate of carbon-particle4 The Scientiﬁc World Journal
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Figure 1: Gadolinium chloride (GdCl3) administration is associated with suppression of Kupﬀer cell functioning in rat liver. Kinetics of
Kupﬀer cell inactivation after GdCl3 treatment (time zero) in livers from euthyroid rats by immunohistochemistry using ED2 antibody (a),
rate of colloidal carbon uptake (b), and carbon-induced liver respiratory activity (ΔQO2) (c) assessed in isolated perfused livers at 72 h after
GdCl3 treatment. ΔQO2 was calculated by integration of the area under the O2 consumption curves between 30 and 45 min perfusion (c).
Values shown represent means ± S E Mf o r4r a t sp e re x p e r i m e n t a lg r o u p .aP<0.05 versus controls assessed by Student’s t-test for unpaired
data.
phagocytosis and the respiratory burst activity of liver
macrophages[13,24].Theuseofthismodelsystemprovided
evidence for the role of Kupﬀer cells in the hepatotoxicity of
lindane[27],acetaminophen[28],andcopper[29],aswellas
Kupﬀer cell function adaptation leading to hepatoprotection
after T3 administration [13, 20]. Data reported in this
study indicate that T3 administration up-regulates liver Nrf2
signaling depending on Kupﬀer cell functioning. Early (2h)
l i v e rN r f 2a c t i v a t i o nt r i g g e r e db yT 3 treatment evidenced
by 4.63-fold enhancement in nuclear/cytosolic Nrf2 ratios
denoting cytosol-to-nuclear Nrf2 translocation, occurred
without signiﬁcant changes in nuclear Keap1/Nrf2 ratios.
These data indicate that T3 achieves liver Nrf2 upregulation
in a time interval at which Nrf2-dependent induction of its
inhibitor Keap1 [30] does not occur, resulting in signiﬁcant
increases in the expression of the target genes controlled
by Nrf2, namely, HO-1, GCLC, and Trx [18]. T3-induced
liverNrf2activationinvolvesaredox-dependentmechanism,
considering that cytosol to nuclear Nrf2 translocation is
blocked by N-acetylcysteine pretreatment [14]. The redox
activation of Nrf2 is associated with ROS produced due
to acceleration of liver O2 consumption by the calorigenic
action of T3 e x e rt e do nh e p a t o c yt e sa n dK u p ﬀer cells [7], but
it also may involve ROS generated in the respiratory burst
activity of hepatic macrophages [13]. The latter proposal
underlies redox activation of NF-κBi nK u p ﬀer-cell of
T3-treated animals [31], with consequent expression and
release of TNF-α, as reported in this study. Interaction ofThe Scientiﬁc World Journal 5
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(P<0.05; two-way ANOVA and the Newman-Keuls’ test) is indicated by the letters identifying each experimental group. Signiﬁcance in the
inset of (c) was calculated by Student’s t-test for unpaired data.
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Figure 4: Apocynin administration is associated with suppression of colloidal carbon-induced liver respiratory activity (ΔQO2) assessed
in isolated perfused livers from euthyroid rats (a), without altering carbon phagocytosis (b). Determinations were carried out 7 days after
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Figure 5: Apocynin administration is associated with diminution of T3-induced activation of liver Nrf2 signaling. Determinations were
p e r f o r m e da t2ha f t e rT 3 administration in rats pretreated with apocynin for 7 days. (a) Levels of cytosolic Nrf2 protein (68kDa) and β-
actin (43kDa); (b) levels of nuclear Nrf2 protein and lamin A/C (65kDa); (c) nuclear/cytosolic Nrf2 content ratios and net eﬀects of T3 and
apocynin treatments (inset); (d) levels of heme oxygenase 1 (HO-1) protein (33kDa). Values shown represent means ± SEM for 3 to 4 rats
per experimental group. Signiﬁcance (P<0.05; two-way ANOVA and the Newman-Keuls’ test) is indicated by the letters identifying each
experimental group. Signiﬁcance in the inset of (c) was calculated by Student’s t-test for unpaired data.8 The Scientiﬁc World Journal
TNF-α with TNF-α receptor-1 in hepatocytes may trigger
mitochondrial ROS production [32, 33], reinforcing that
achieved by actions of T3 on hepatocyte energy metabolism.
Under these conditions, Nrf2 activation may be achieved by
direct action of ROS [17–19] or through ROS-dependent
formation of cyclopentenone-containing J isoprostanes from
polyunsaturatedfattyacids,whichreleaseNrf2uponbinding
to Keap1 [34, 35]. In addition, increased formation of
Nrf2/c-Jun complexes may occur due to the ability of TNF-α
to induce c-Jun nuclear-binding activity [36], heterodimer-
ization that is required for ARE-mediated transcriptional
activation [37].
Dependency of T3-induced liver Nrf2 upregulation on
Kupﬀer cells was demonstrated by inactivation of liver
macrophages by GdCl3 [21] or inhibition of Kupﬀer-cell
NADPH oxidase activity by apocynin [22, 38]. Administra-
tion of the GdCl3 72h prior to T3 achieved almost complete
elimination of ED2(+) cells, a Kupﬀer cell subpopulation
characterized with a ED2 antibody recognizing a membrane
antigen of resident macrophages such as Kupﬀer cells [39,
40]. Liver ED2(+) cells are described as mature macrophages
[41], which are mainly located in periportal areas of the
liver lobule [42] .T h e s em a t u r el i v e rm a c r o p h a g e sh a v e
higher lysosomal enzyme activities, phagocytic capacity, and
production of TNF-α, interleukin-1 and prostaglandin E2
than smaller ED1(+) cells located in midzonal and central
areas [1], a subpopulation of liver macrophages that is not
modiﬁed by GdCl3 administration [20]. Under conditions
of GdCl3-induced Kupﬀer-cell depletion, activation of Nrf2
and expression of HO-1, GCLC, and Trx by T3 were
abolished, concomitantly with signiﬁcant enhancement in
nuclear Keap1/Nrf2 ratios. The latter ﬁnding suggests that
the nuclear abundance of Keap1 is increased by combined
GdCl3-T3 treatment, which may allow an eﬃcient nuclear
export mechanism to terminate T3-induced Nrf2 signaling
[43]. In agreement with these views, T3-induced TNF-α
response is abolished in rats subjected to combined GdCl3-
T3 treatment, which may suppress Kupﬀer cell-dependent
TNF-α-induced mitochondrial ROS component, otherwise
altering Keap1 to a form which does not have anti-Nrf2
eﬀects[19] .T h er o l eo fK u p ﬀer cells in T3-induced liver Nrf2
activation suggested by hepatic macrophage depletion after
GdCl3 administration is further supported by experiments
using apocynin prior to T3. Apocynin inhibits the assembly
of the ROS generator NADPH oxidase in neutrophils and
macrophages after metabolic conversion, without altering
phagocytosis, in addition to its free-radical scavenging
properties [38]. In addition, Kupﬀer cell activation by
hepatic IR upregulates kidney Nrf2 signaling to avoid remote
organ dysfunction, as treatment with GdCl3 prior to liver
IR attenuates the TNF-α response induced, reducing the
enhancement in renal levels of the Nrf2 activator 15-deoxy-
Δ12,14-protaglandinJ2,Nrf2nucleartranslocation,andHO-1
expression [34].
5. Conclusion
Data presented suggest that Kupﬀer cell functioning is essen-
tial for upregulation of liver Nrf2 stress response-signaling
pathway by T3. This is demonstrated by the abolishment
of Nrf2 activation and Nrf2-dependent expression of HO-1,
GCLC, and Trx by GdCl3-induced Kupﬀer cell depletion and
apocynin inhibition of macrophage NADPH oxidase, when
givenpriortoT3. These agents abrogate the respiratory burst
activity of Kupﬀer cells and the associated ROS production,
thus hindering Nrf2 activation. Data presented and the
signiﬁcant diminution in T3-induced changes in hepatic
oxidative stress-related parameters by GdCl3 pretreatment,
namely, reduced glutathione depletion and enhancement in
lipid peroxidation and in the biliary glutathione disulﬁde
release [13, 44], point to the crucial role of Kupﬀer cell
functioning in mediating T3-dependent cytoprotection in
the liver. This is understood in terms of T3-induced Kupﬀer
cell-dependent development of a suitable prooxidant status
in hepatocytes triggering the activation of protective, redox-
sensitive transcription factors such as Nrf2, as well as NF-κB,
STAT3, and AP-1 [7].
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